Share Price:

APNASPENAspen Pharmacare Hldgs18560-330 (-1.75%)
Our Response to Covid
Country Sites

Year: 2018

Aspen launches novel ARV Combination: Set to further improve treatment options

Johannesburg: Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of EmdoltenTM, a Dolutegravir-based triple combination anti-retroviral (ARV) treatment option. EmdoltenTM, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will… Continue reading Aspen launches novel ARV Combination: Set to further improve treatment options

Aspen’s participation in the 2018 Investment Conference

Sandton – Aspen welcomes President Ramaphosa’s inaugural Investment Conference, aimed at positioning South Africa as a preferred investment destination and at establishing a more predictable and stable investment environment in our country. Amongst other initiatives, this includes facilitating the ease of doing business and reducing unnecessary regulatory burden in the South African pharmaceutical sector. These… Continue reading Aspen’s participation in the 2018 Investment Conference

Aspen supports the World Thrombosis Day campaign

Aspen remains committed to the World Thrombosis Day campaign to raise awareness of thrombosis as an urgent and growing public health problem. PARIS, FRANCE – Aspen has reinforced its commitment to fight thrombosis worldwide through its long-standing partnership with the International Society on Thrombosis and Haemostasis (ISTH) World Thrombosis Day (WTD) campaign. This initiative aims to… Continue reading Aspen supports the World Thrombosis Day campaign

Aspen’s revenue increases to R42.6 billion

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced today, in conjunction with the announcement of its annual results for the year ended 30 June 2018, that it has concluded an agreement to divest of its global Nutritional Business to the Lactalis Group Stephen Saad, Aspen Group… Continue reading Aspen’s revenue increases to R42.6 billion

Aspen meets with French Prime Minister Philippe and members of his cabinet

Aspen was one of the few companies invited by French Prime Minister Edward Philippe to attend the Health Industry Strategic Meeting on 9 July 2018 at the Matignon, Paris – the official office of the Prime Minister. Represented by Stavros Nicolaou and Fabrice Jover, Aspen had an opportunity to hold brief discussions with Prime Minister… Continue reading Aspen meets with French Prime Minister Philippe and members of his cabinet

Aspen’s continued commitment to Mandela Day

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, is, for the eighth consecutive year, participating in Mandela Day through activities hosted by its businesses spanning 6 continents. Stephen Saad, Aspen Group Chief Executive said, “We heeded the Mandela Day call for the first time in 2011 and we… Continue reading Aspen’s continued commitment to Mandela Day

Realising Joost’s dream for MND care

Through public private partnership the Gauteng Department of Health and Chris Hani Baragwanath Academic Hospital (CHBAH) gave recognition to their Motor Neuron Disease (MND) clinic as a center of excellence to intensify its health care services. This is in response to a  desperate need to offer special care to patients who are suffering from this… Continue reading Realising Joost’s dream for MND care

Aspen opens R1 billion high containment facility

Port Elizabeth – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, officially opened its R1 billion Port Elizabeth-based high containment facility earlier today. Stephen Saad, Aspen Group Chief Executive said, “Aspen continues its evolution into a global specialty manufacturer of niche products requiring complex technologies. The high potency manufacturing facility we are opening… Continue reading Aspen opens R1 billion high containment facility

Our Purpose

Find out more

To improve the health and quality of life of patients.

Our Vision

Find out more

To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more

Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600

Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.